Treatment of OCD with SSRIs and Vyvanse

First-Line Treatment Options for OCD

The American College of Neurology and Psychiatry recommends SSRIs as the first-line pharmacological treatment for OCD due to their established efficacy, tolerability, safety profile, and absence of abuse potential 1, 2
Higher doses of SSRIs are typically required for OCD treatment compared to those used for anxiety disorders or depression, with a treatment duration of at least 8-12 weeks at the optimal dose to determine efficacy 2, 5
Common SSRIs used for OCD include fluoxetine, sertraline, paroxetine, fluvoxamine, and escitalopram, with a recommended treatment approach of starting with a low dose and gradually titrating up to the maximum tolerated or recommended dose 2, 4

The International College of Neurology and Psychiatry suggests starting with an SSRI and allowing at least 8-12 weeks at the optimal dose to determine efficacy, with the option to switch to a different SSRI if there is an inadequate response 1, 5
For patients with partial response, adding cognitive-behavioral therapy with exposure and response prevention (ERP) if available, or considering augmentation strategies if needed, is recommended 1, 7
The maintenance treatment should continue effective medication for at least 12-24 months after achieving remission due to high risk of relapse, as recommended by the American College of Neurology and Psychiatry 5, 3

For patients with comorbid ADHD and OCD, the combination of Vyvanse and an SSRI is particularly appropriate, as recommended by the American Academy of Child and Adolescent Psychiatry 1